Central line-associated bloodstream infection (CLABSI) event data reported to the National Healthcare Safety Network from 2014, the first year of required use of the mucosal barrier injury laboratoryconfirmed bloodstream infection (MBI-LCBI) definition, were analyzed to assess the impact of removing MBI-LCBI events from CLABSI rates. CLABSI rates decreased significantly in some location types after removing MBI-LCBI events, and MBI-LCBI events will be removed from publicly reported CLABSI rates.
In 2013, the National Healthcare Safety Network (NHSN) introduced the mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) definition in the NHSN protocol for surveillance of bloodstream infections. The MBI-LCBI definition was developed to enable surveillance staff in hospitals to identify and report bloodstream infections in oncology patients that likely were the result of mucosal barrier injury and therefore not preventable through recommended central line insertion and maintenance practices. 1 Analysis of the first year of MBI-LCBI data reported to the NHSN suggested that excluding MBI-LCBI events from central line-associated bloodstream infection (CLABSI) rates would result in large (>40%) overall reductions in CLABSI rates from inpatient oncology locations but would only reduce CLABSI rates modestly nationwide. 2 However, reporting whether CLABSIs fulfilled the MBI-LCBI criteria during 2013 was an optional part of the CLABSI protocol. 2 Whether required reporting of MBI-LCBI would result in a different impact on overall CLABSI rates was unclear. Here, we describe the epidemiology of MBI-LCBI events reported to the NHSN in 2014, the first year that identification of MBI-LCBI events was required by the NHSN CLABSI protocol.
METHODS
We analyzed all 2014 CLABSI data reported to the NHSN from inpatient locations in short-term acute care hospitals. Other hospital types were excluded because few or no MBI-LCBI events were reported. Inpatient location types (eg, adult and pediatric ward and critical care, adult and pediatric oncology ward and critical care) were designated by the reporting hospitals. 3 Definitions of CLABSI and MBI-LCBI can be found in the NHSN CLABSI protocol. 4 We described hospital and location types reporting MBI-LCBI events. For simplicity, all location types not specified as pediatric are referred to here as adult. Pooled mean CLABSI rates per 1,000 central line days were calculated as (number of CLABSI) × 1,000 / (number of central line days), both including and excluding MBI-LCBI events. Pooled mean rates for 2014 were stratified by inpatient location type. All analyses were performed with SAS 9.3 (SAS Institute, Cary, NC).
RESULTS
CLABSI data were reported from 16,755 inpatient locations from 3,293 hospitals in 2014. The most common hospital types were general (95.4%) and children's (2.3%), and the most common location types were adult ward (47.3%), adult critical care (30.5%), and neonatal intensive care (6.0%).
During 20,691,116 central line days of surveillance, these hospitals and inpatient locations reported 19,130 CLABSIs, of which 2,017 (10.5%; 95% confidence interval [CI], 9.3%-11.8%) were reported as MBI-LCBI events (Table 1) . Most MBI-LCBI events were reported from general hospitals (71.0%), oncology hospitals (15.3%), and children's Table 1) . Reductions in pooled mean CLABSI rates were smaller among nononcology locations, including pediatric ward (11.9% reduction; 95% CI, 1.5%-20.3%), adult ward (5.1%; 95% CI, 2.3%-7.8%), and adult critical care locations (1.9%; 95% CI, −0.4% to 4.0%). The CLABSI rate including MBI-LCBIs was 1.8 per 1,000 central line days for adult oncology wards; when MBI-LCBI events were excluded, the rate dropped to 1.0 per 1,000 central line days. In contrast, in adult nononcology wards, exclusion of MBI-LCBI events had no impact on the CLABSI rate, which was 0.7 per 1,000 central line days with and without MBI-LCBI events.
DISCUSSION
Quantification of the impact of removing MBI-LCBIs from CLABSI data is necessary to enable accurate interpretation of CLABSI trends over time and inform changes to state and federal reporting programs. This examination of data from the first year of required MBI-LCBI reporting in the NHSN found that overall approximately 1 in 10 (10.5%) CLABSI met the MBI-LCBI definition. Most MBI-LCBIs were reported from oncology locations, and pediatric locations (both ward and critical care) had a higher proportion of CLABSIs that were MBI-LCBI events than their adult counterparts. Importantly, our findings show the exclusion of MBI-LCBI events from the calculation of CLABSI rates primarily reduced the pooled mean CLABSI rates in oncology locations by approximately 30% (in adult oncology critical care) and up to 48% (in pediatric oncology wards). Excluding MBI-LCBI events reduced differences between CLABSI rates in these oncology location types and the corresponding nononcology locations. Although in pediatric oncology critical care locations reductions in CLABSI rates appear to be more modest, few events overall were reported in this location type making comparisons limited. These findings are largely consistent with what was seen from optional CLABSI reporting. 2 This analysis does not directly address potential differences in patient mix among a single NHSN location type; however, the MBI-LCBI definition is likely to be of benefit when such differences are related to the presence of oncology patients in some locations and not others. The Centers for Disease Control and Prevention is using 2015 NHSN data to update models used for risk adjustment of health careassociated infection rates, including CLABSIs. MBI-LCBI events will be excluded from publicly reported CLABSI rates in the updated models beginning with 2015 data. This change should bolster efforts to identify locations or facilities where improvements in central line care are most needed for CLABSI prevention. 5, 6 In addition, although the MBI-LCBI definition was developed to enable identification of bloodstream infections that may not be related to central line care and maintenance, MBI-LCBI events in themselves are important targets for prevention because they also represent significant health care-related adverse events. The development of the MBI-LCBI definition and the subsequent refinement of the CLABSI definition highlight the NHSN's commitment to ensuring the utility of its data for directing prevention needs locally and guiding public policy decisions.
